US FDA approves Roche's Actemra for previously treated RA - update
12 January 2010
Asher Mullard
Please Login to read the full article.
12 January 2010
Asher Mullard
The
US FDA has approved
Roche's first-in-class IL-6-receptor inhibiting monoclonal antibody Actemra (tocilizumab) for the treatment of moderate-to-severely active rheumatoid arthritis (RA) in patients who are unresponsive to TNF inhibitors. The drug will be available in the US from January...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
